Skip to main content
. Author manuscript; available in PMC: 2021 Aug 10.
Published in final edited form as: Int Arch Allergy Immunol. 2020 Aug 10;181(11):879–887. doi: 10.1159/000509600

Table 5.

FEV1 (% predicted) at baseline and post-intramuscular triamcinolone acetonide (TA) administration in BPS-low (below median BPS) and BPS-high (above median) patients

Visit
Group Baseline Post-TA p
Below median/BPS-low (27) 84 ± 19 87 ± 20 0.002
Above median/BPS-high (27) 74 ± 22 75 ± 22* 0.43

Data are presented as mean ± SD. FEV1 = pre-bronchodilation FEV1. BPS, baseline P-selectin; FEV1, forced expiratory volume in 1 s.

*

p ≤ 0.05 versus BPS-low (< 23.1 ng/ml).